AWM
DXCM icon

AE Wealth Management’s DexCom DXCM Stock Holding History

AE Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$783K Sell
11,627
-2,335
-17% -$156K ﹤0.01% 1012
2026
Q1 		$877K Sell
13,962
-72
-0.5% -$5.01K ﹤0.01% 875
2025
Q4 		$931K Sell
14,034
-17,540
-56% -$1.13M 0.01% 821
2025
Q3 		$2.12M Buy
31,574
+6,873
+28% +$544K 0.01% 552
2025
Q2 		$2.16M Buy
24,701
+8,283
+50% +$649K 0.02% 520
2025
Q1 		$1.12M Sell
16,418
-689
-4% -$56.2K 0.01% 674
2024
Q4 		$1.33M Sell
17,107
-1,550
-8% -$115K 0.01% 643
2024
Q3 		$1.25M Buy
+18,657
New +$1.53M 0.01% 652
2024
Q1 		– Sell
-11,278
Closed -$1.38M – 1367
2023
Q4 		$1.38M Buy
11,278
+5,266
+88% +$538K 0.01% 1045
2023
Q3 		$561K Sell
6,012
-808
-12% -$91.1K ﹤0.01% 1317
2023
Q2 		$876K Buy
6,820
+2,852
+72% +$345K 0.01% 1141
2023
Q1 		$461K Sell
3,968
-698
-15% -$78.1K ﹤0.01% 1384
2022
Q4 		$528K Buy
4,666
+948
+25% +$104K ﹤0.01% 1288
2022
Q3 		$299K Sell
3,718
-58
-2% -$4.91K ﹤0.01% 1476
2022
Q2 		$281K Sell
3,776
-36
-0.9% -$3.29K ﹤0.01% 1462
2022
Q1 		$488K Buy
3,812
+4
+0.1% +$438 ﹤0.01% 1243
2021
Q4 		$511K Buy
3,808
+312
+9% +$44.8K ﹤0.01% 1239
2021
Q3 		$478K Buy
3,496
+24
+0.7% +$3.03K ﹤0.01% 1186
2021
Q2 		$371K Sell
3,472
-584
-14% -$56.1K ﹤0.01% 1254
2021
Q1 		$364K Sell
4,056
-664
-14% -$62.3K ﹤0.01% 1185
2020
Q4 		$436K Buy
4,720
+80
+2% +$7.14K ﹤0.01% 1009
2020
Q3 		$478K Sell
4,640
-14,440
-76% -$1.51M 0.01% 892
2020
Q2 		$1.93M Buy
19,080
+15,844
+490% +$1.42M 0.03% 423
2020
Q1 		$218K Buy
+3,236
New +$201K 0.01% 979

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AE Wealth Management's DXCM Position: Q2 2026 in Review

AE Wealth Management reduced its DexCom (DXCM) stake by 17% in Q2 2026, selling an estimated $156K and leaving 11,627 shares worth $783K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

AE Wealth Management first reported a position in DXCM in Q1 2020 and has held it in 24 quarters since. The position peaked at $2.16M in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • AE Wealth Management held 11,627 shares of DexCom worth $783K as of Q2 2026.
  • AE Wealth Management sold 2,335 DexCom shares in Q2 2026, an estimated $156K.
  • DexCom made up ﹤0.01% of AE Wealth Management's portfolio in Q2 2026, its #1012 holding.
  • AE Wealth Management first reported a position in DexCom in Q1 2020 and has held it in 24 quarters since.
  • AE Wealth Management's DexCom position peaked at $2.16M in Q2 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.